Global Appetite for K-Food Drives Record Export Surge as Instant Noodles and Frozen Gimbap Soar
The global spread of Korean pop culture continues to drive unprecedented overseas demand for K-food products, with items like instant ramen, frozen...
Search results for "global"
2026 World Cup Looms as Outbreaks of Measles and Ebola Raise Global Health Concerns
The world’s largest sporting event, the FIFA World Cup, is now just three weeks away. However, persistent outbreaks of infectious diseases across...
Samsung Bioepis Expands Global Open Innovation via Partnership With Chinese Biotech Hub
Samsung Bioepis announced on the 29th that it has signed a memorandum of understanding with Atlalt Innovation Center, a...
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions
Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
![[USA-NIH] Why the NIH, Home to 174 Nobel Laureates, Attracts a Global Elite of Physician-Scientists](https://cdn.kormedi.com/wp-content/uploads/2025/09/gettyimages-2225315935.jpg)
[USA-NIH] Why the NIH, Home to 174 Nobel Laureates, Attracts a Global Elite of Physician-Scientists
The chronic crisis in domestic healthcare extends beyond the collapse of essential services; it is also a crisis of...
Global Competition to Cultivate 'Good Doctors' Transforms Medical Classrooms
From Technical Instruction to Patient-Centered Care “How do you tell a patient they have terminal cancer.
Golden Globe Winner EJAE Reveals the Wellness Regimen Behind Her Global Success
Korean-American singer-songwriter EJAE (Kim Eun-jae, 34) is stepping into the global spotlight after her track...
"K-Health Content for 4.7 Billion People": Kormedi.com Launches Global Multilingual Service
Kormedi. com, South Korea’s premier health and medical media outlet, is officially going global.
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...